World ADC (Antibody Drug Conjugates) Summit (ADC)

Venue: San Francisco

Location: San Francisco, United States

Event Date/Time: Oct 26, 2011 End Date/Time: Oct 27, 2011
Report as Spam


Building on last year’s hugely successful sell-out program, attend this meeting to address the challenges you are facing in R&D, clinical development, regulatory requirements, characterization and antibody processing.
And this year we’ve worked with our ADC Advisory Board: Paul Polakis (Genentech), John Lambert (ImmunoGen), Hans Peter Gerber (Pfizer), Sanjeev Gangwar, Dennis Benjamin (Seattle Genetics) and Peter Senter (Seattle Genetics) to bring you the most innovative and valuable program yet!
Register your place today to:
• Get the latest clinical updates on T-DM1, SGN-35, CDX-11 and more
• Discover the approaches to attaining favorable PK profiles
• Find out the advances in linker technology, payload chemistry to optimize conjugate design earlier in development
• Understand the latest thinking on mechanisms of drug-resistance
• Be equipped with the regulatory guidance you need to successfully navigate the development process
• Gain an insight into Roche’s conjugated bispecific platform
• Overcome challenges in the characterization and process development of ADCs
• Determine what tox, safety and efficacy you need to include in your IND package
For more information please visit the meeting website at Here you can view the full speaker line up and agenda.
To register simply:
Call: +1 212 537 5898
Please quote the booking code: EXTLIST when registering to secure your place at the meeting.